Press Releases

Press Release

Cardiol Therapeutics Appoints Dr. Andrew Hamer as New Chief Medical Officer

March 30, 2021

Press Release

Cardiol Therapeutics Submits Application for Uplisting to the Nasdaq and Raises Proceeds of Over $10 Million from Exercise of Warrants and Options

March 02, 2021

Press Release

Cardiol Therapeutics Announces Formation of Data Safety Monitoring and Clinical Endpoint Committees for Phase II/III Outcomes Trial in High-Risk Patients Hospitalized with COVID-19

January 21, 2021

Press Release

Cardiol Therapeutics to Participate in Upcoming Virtual Investor Conferences

January 07, 2021

Press Release

Cardiol Therapeutics Announces Completion of Phase I Clinical Study of CardiolRx™

December 22, 2020

Press Release

Cardiol Therapeutics Appoints Worldwide Clinical Trials as CRO for the Company’s Phase II/III Outcomes Trial in High-risk Patients Hospitalized with COVID-19

December 15, 2020

Press Release

Cardiol Therapeutics’ Cortalex™ CBD Now Available Exclusively Online at Medical Cannabis by Shoppers Inc.

October 20, 2020

Press Release

Cardiol Therapeutics Receives FDA Approval for Investigational New Drug (IND) Application for Phase II/III COVID-19 Trial

September 25, 2020

Press Release

Cardiol Therapeutics to Present at the H.C. Wainwright Virtual 22nd Annual Global Investment Conference

September 15, 2020